Verde Science forms R and D Alliance

Richmond, BC - September 23, 2014 - InvestorsHub NewsWire - Verde Science, Inc., a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems for the production of pure, efficacious Medical Marijuana, is pleased to announce a Research and Development Alliance with a Mumbai, India based pharmaceutical company that has a record of significant success in the development of novel medical treatment compounds.  This new relationship will allow Verde to launch immediately on its THC Pharmaceutical Development Program, and accelerate its R and D operations by about one year.  Without this important alliance Verde would have experienced unnecessary delays as it waited for its Research and Development License in Canada.  According to Harp Sangha, Verde’s Chairman and CEO, “Now we can immediately access the vast treasure of our Indian partner’s intellectual capital and tap into a highly educated organization of research scientists in a cost effective manner.” 

The researchers in India will be planning and executing a comprehensive research program which would not be possible for several months to a year in Canada due to the waiting period for obtaining a Canadian R and D license.  They will also prepare protocols for clinical trials which can be conducted immediately in India and subsequently in Canada after Verde obtains its R and D license.  The company plans to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs for a variety of ailments such as chronic pain, inflammation, migraines, seizures related to epilepsy, nausea associated with cancer treatment, and numerous others.

“This new Research and Development Program with a focus on developing custom formulations for specific medical issues will firmly place Verde on the cutting edge of cannabinoid and THC technology in treating illness, and our association with our new Indian partner will enable us to become a clearing house for research into new applications for marijuana based treatments of a variety of illnesses.   The Verde brand will be synonymous with innovation into natural based remedies for a variety of debilitating illnesses.” stated Mr. Sangha.
About Verde Science, Inc. (VRCI)
 
Verde Science, Inc. (www.VerdeScienceInc.com) is a public company trading under the symbol OTCQB: VRCI.  The Company is focused on Medical Marijuana Research and Development, and providing advisory services, quality assurance, and aeroponic growing systems in the burgeoning Medical Marijuana industry to established, licensed growers throughout Canada.

Safe Harbor Statements?Certain information contained in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates", "intends" or "believes", or that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur", or "be achieved". Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.

For further information please contact:


Harp Sangha Chairman/CEO
1-858-210-0236
[e-mail]